Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026)
Bausch & Lomb (BLCO) posted Income from Non-Controlling Interests of $1.0 million for Q1 2026, down 66.67% on a QoQ basis from $3.0 million in Q3 2025, and little changed year-over-year from $1.0 million in Q1 2025.
Bausch & Lomb (BLCO) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Bausch & Lomb's Income from Non-Controlling Interests history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Income from Non-Controlling Interests changed 0.0% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (down 11.11% YoY) and the FY2025 annual result came in at $8.0 million, down 33.33% from the prior year.
- Income from Non-Controlling Interests was $1.0 million for Q1 2026 at Bausch & Lomb, down from $3.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $4.0 million in Q3 2023 and bottomed at $1.0 million in Q4 2022.
- A 5-year average of $2.6 million and a median of $3.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests surged 200.0% — and 2025, when it plunged 75.0%.
- Bausch & Lomb's Income from Non-Controlling Interests stood at $1.0 million in 2022, then jumped by 200.0% to $3.0 million in 2023, then plunged by 66.67% to $1.0 million in 2024, then jumped by 200.0% to $3.0 million in 2025, then plunged by 66.67% to $1.0 million in 2026.
- Business Quant data shows BLCO's Income from Non-Controlling Interests at $1.0 million in Q1 2026, $3.0 million in Q3 2025, and $4.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -18.70 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Bausch & Lomb | 5.79 Bn | 5.51 Bn | 973.00 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Mar 31, 2021 | 3.00 Mn |